Carlson College of Veterinary Medicine

C. Adriano de Silva, Rojony, R., Bermudez, L. E., and Danelishvili, L., “Short-Chain Fatty Acids Promote subsp. Growth in Nutrient-Limited Environments and Influence Susceptibility to Antibiotics.”, Pathogens, vol. 9, no. 9, 2020.

A. E. Parker and Bermudez, L. E., “Sequence and characterization of the glyceraldehyde-3-phosphate dehydrogenase of Mycobacterium avium: correlation with an epidermal growth factor binding protein.”, Microbial pathogenesis, vol. 28, no. 3, pp. 135-44, 2000.

L. Danelishvili, Yamazaki, Y., Selker, J., and Bermudez, L. E., “Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins participate in the suppression of macrophage apoptosis.”, PLoS One, vol. 5, no. 5, p. e10474, 2010.

L. Danelishvili, Yamazaki, Y., Selker, J., and Bermudez, L. E., “Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins participate in the suppression of macrophage apoptosis.”, PloS one, vol. 5, no. 5, p. e10474, 2010.

L. E. Bermudez, Kolonoski, P., and Young, L. S., “Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.”, Antimicrobial agents and chemotherapy, vol. 40, no. 4, pp. 1033-5, 1996.

S. R. Byrd, Gelber, R., and Bermudez, L. E., “Roles of soluble fibronectin and beta 1 integrin receptors in the binding of Mycobacterium leprae to nasal epithelial cells.”, Clinical immunology and immunopathology, vol. 69, no. 3, pp. 266-71, 1993.

L. Danelishvili and Bermudez, L. E., “Role of type I cytokines in host defense against Mycobacterium avium infection.”, Current pharmaceutical design, vol. 9, no. 1, pp. 61-5, 2003.

L. Danelishvili and Bermudez, L. E., “Role of type I cytokines in host defense against Mycobacterium avium infection.”, Curr Pharm Des, vol. 9, no. 1, pp. 61-5, 2003.

J. H. Champsi, Bermudez, L. E., and Young, L. S., “The role of cytokines in mycobacterial infection.”, Biotherapy (Dordrecht, Netherlands), vol. 7, no. 3-4, pp. 187-93, 1994.

L. E. Bermudez, Goodman, J., and Petrofsky, M., “Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice.”, Infection and immunity, vol. 67, no. 9, pp. 4912-6, 1999.

L. E. Bermudez, Young, L. S., and Inderlied, C. B., “Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells.”, Antimicrobial agents and chemotherapy, vol. 38, no. 5, pp. 1200-2, 1994.

N. Hsu, Young, L. S., and Bermudez, L. E., “Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with the Mycobacterium avium complex.”, Infection and immunity, vol. 63, no. 2, pp. 528-33, 1995.

L. E. Bermudez and Petrofsky, M., “Regulation of the expression of Mycobacterium avium complex proteins differs according to the environment within host cells.”, Immunology and cell biology, vol. 75, no. 1, pp. 35-40, 1997.

L. E. Bermudez, Martinelli, J., Petrofsky, M., Kolonoski, P., and Young, L. S., “Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.”, The Journal of infectious diseases, vol. 169, no. 3, pp. 575-80, 1994.

L. E. Bermudez and Young, L. S., “Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex.”, Journal of leukocyte biology, vol. 48, no. 1, pp. 67-73, 1990.

L. E. Bermudez and Kaplan, G., “Recombinant cytokines for controlling mycobacterial infections.”, Trends in microbiology, vol. 3, no. 1, pp. 22-7, 1995.

R. Rojony, Martin, M., Campeau, A., Wozniak, J. M., Gonzalez, D. J., Jaiswal, P., Danelishvili, L., and Bermudez, L. E., “Quantitative analysis of subsp proteome in response to antibiotics and during exposure to different environmental conditions.”, Clin Proteomics, vol. 16, p. 39, 2019.

L. E. Bermudez, Martinelli, J. C., Gascon, R., Wu, M., and Young, L. S., “Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.”, Cytokine, vol. 2, no. 4, pp. 287-93, 1990.

L. E. Bermudez, “Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.”, Journal of immunology (Baltimore, Md. : 1950), vol. 150, no. 5, pp. 1838-45, 1993.

J. Champsi, Young, L. S., and Bermudez, L. E., “Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.”, Immunology, vol. 84, no. 4, pp. 549-54, 1995.

C. Hill, Pan, M., Babrak, L., Danelishvili, L., de Morais, H. Autran, and Bermudez, L. E., “Presence of Virulence-Associated Genes and Ability to Form Biofilm among Clinical Isolates of Causing Urinary Infection in Domestic Animals.”, Adv Microbiol, vol. 5, no. 8, pp. 573-579, 2015.

L. S. Young, Bermudez, L. E., and Inderlied, C. B., “Practical issues in the antibiotic and immunotherapy of Mycobacterium avium disease in immunocompromised patients.”, Research in microbiology, vol. 145, no. 3, pp. 206-9, 1994.

L. E. Bermudez, “Potential role of cytokines in disseminated mycobacterial infections.”, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13 Suppl 2, pp. S29-33, 1994.

L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B., “Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.”, The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.

L. E. Bermudez, “[Post-antibiotic effect in the treatment of infections in neutropenic patients].”, Revista do Hospital das Clínicas, vol. 41, no. 2, pp. 76-9, 1986.